(Q34517576)

2 August 2017

1 reference

title

Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid (English)

1 reference

2 August 2017

0 references

1 reference

Wolf-Ingo Worret

1

1 reference

2 August 2017

Joachim W Fluhr

series ordinal

2

1 reference

2 August 2017

language of work or name

German

0 references

publication date

1 April 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

4

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

293-300

1 reference

Oxidative targets in the stratum corneum. A new basis for antioxidative strategies

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

An overview of topical antibiotics for acne treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Is antibiotic resistance in cutaneous propionibacteria clinically relevant? : implications of resistance for acne patients and prescribers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Antibiotic-resistant acne: lessons from Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Clindamycin vs Placebo as Adjunctive Therapy in Moderately Severe Acne

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Pseudomembranous colitis after topical application of clindamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

The Effect Of Oral And Topical Tetracycline On Acne Severity And On Surface Lipid Composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Topical use of tetracycline in the treatment of acne: a double-blind study comparing topical and oral tetracycline therapy and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1610-0387.2006.05931.X

10.1111/J.1610-0387.2006.05931.X

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference